Sensus Healthcare, Inc. (SRTS)
NASDAQ: SRTS · Real-Time Price · USD
5.38
-0.18 (-3.24%)
At close: Feb 21, 2025, 4:00 PM
5.39
+0.01 (0.19%)
After-hours: Feb 21, 2025, 6:24 PM EST
Sensus Healthcare Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
Revenue | 41.81 | 24.41 | 44.53 | 27.04 | 9.58 | Upgrade
|
Revenue Growth (YoY) | 71.31% | -45.20% | 64.68% | 182.36% | -64.87% | Upgrade
|
Cost of Revenue | 17.38 | 10.35 | 14.9 | 10.05 | 4.33 | Upgrade
|
Gross Profit | 24.43 | 14.06 | 29.63 | 16.99 | 5.25 | Upgrade
|
Selling, General & Admin | 12.13 | 10.76 | 11.34 | 9.43 | 9.33 | Upgrade
|
Research & Development | 4.22 | 3.68 | 3.46 | 3.44 | 4.16 | Upgrade
|
Operating Expenses | 16.34 | 14.44 | 14.8 | 12.87 | 13.48 | Upgrade
|
Operating Income | 8.09 | -0.38 | 14.83 | 4.12 | -8.23 | Upgrade
|
Interest Expense | - | - | - | -0 | -0.01 | Upgrade
|
Interest & Investment Income | 0.93 | 0.99 | 0.38 | 0 | 0.07 | Upgrade
|
EBT Excluding Unusual Items | 9.02 | 0.61 | 15.21 | 4.12 | -8.18 | Upgrade
|
Gain (Loss) on Sale of Assets | - | 0.04 | 12.78 | -0 | - | Upgrade
|
Other Unusual Items | - | - | - | - | 1.35 | Upgrade
|
Pretax Income | 9.02 | 0.65 | 27.99 | 4.12 | -6.84 | Upgrade
|
Income Tax Expense | 2.38 | 0.17 | 3.75 | - | - | Upgrade
|
Net Income | 6.65 | 0.49 | 24.24 | 4.12 | -6.84 | Upgrade
|
Net Income to Common | 6.65 | 0.49 | 24.24 | 4.12 | -6.84 | Upgrade
|
Net Income Growth | 1270.52% | -98.00% | 488.59% | - | - | Upgrade
|
Shares Outstanding (Basic) | 16 | 16 | 16 | 16 | 16 | Upgrade
|
Shares Outstanding (Diluted) | 16 | 16 | 17 | 17 | 16 | Upgrade
|
Shares Change (YoY) | 0.57% | -2.12% | 0.70% | 0.42% | 1.24% | Upgrade
|
EPS (Basic) | 0.41 | 0.03 | 1.47 | 0.25 | -0.42 | Upgrade
|
EPS (Diluted) | 0.41 | 0.03 | 1.46 | 0.25 | -0.42 | Upgrade
|
EPS Growth | 1266.06% | -97.96% | 484.00% | - | - | Upgrade
|
Free Cash Flow | - | -2.37 | -1.57 | -0.41 | -0.79 | Upgrade
|
Free Cash Flow Per Share | - | -0.15 | -0.09 | -0.03 | -0.05 | Upgrade
|
Gross Margin | 58.44% | 57.61% | 66.53% | 62.82% | 54.81% | Upgrade
|
Operating Margin | 19.35% | -1.57% | 33.30% | 15.24% | -85.98% | Upgrade
|
Profit Margin | 15.90% | 1.99% | 54.44% | 15.23% | -71.38% | Upgrade
|
Free Cash Flow Margin | - | -9.73% | -3.53% | -1.53% | -8.28% | Upgrade
|
EBITDA | 8.3 | -0.11 | 15.15 | 4.73 | -7.51 | Upgrade
|
EBITDA Margin | 19.84% | -0.44% | 34.01% | 17.50% | -78.44% | Upgrade
|
D&A For EBITDA | 0.21 | 0.28 | 0.32 | 0.61 | 0.72 | Upgrade
|
EBIT | 8.09 | -0.38 | 14.83 | 4.12 | -8.23 | Upgrade
|
EBIT Margin | 19.35% | -1.57% | 33.30% | 15.24% | -85.98% | Upgrade
|
Effective Tax Rate | 26.32% | 25.61% | 13.38% | - | - | Upgrade
|
Advertising Expenses | - | 1.2 | 0.9 | 0.46 | 0.52 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.